Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines in oncology, today announced that Laura J. Esserman, MD ...

A polygenetic risk score can predict which women with in situ breast cancer will develop invasive disease and guide clinical ...

A common vitamin could help prevent the development of skin cancer, new research suggests. The study, published in JAMA Dermatology, found a decreased risk of three types of skin cancer associated ...

1 Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China 2 Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China ...

ABSTRACT: Breast cancer is one of the most common malignant tumors in women worldwide, posing a serious threat to women’s health. The incidence of breast cancer is on the rise, and the proportion of ...

An international research team has identified a previously unknown mechanism by which the breast cancer drug tamoxifen can increase the risk of secondary tumors in the uterus. The study shows that ...

Gynecomastia can indicate underlying health concerns, including cancer, and surgery provides an opportunity to examine tissues for abnormalities. Early detection saves lives. SINGAPORE, Aug. 6, 2025 ...

Aug 5 (Reuters) - Uranium Energy's (UEC.A), opens new tab Sweetwater Uranium Complex in Wyoming has been selected by the U.S. government for a fast-tracked process of approval to add in-situ recovery ...

ANKTIVA, a first-in-class, lymphocyte-stimulating agent, works synergistically with BCG to activate and proliferate natural killer (NK) and T cells, helping eliminate cancer Already approved in the ...

Clin Cancer Res (2025) 31 (12_Supplement): P2-07-06. Introduction: Breast cancer accounts for 12.5% of all new annual cancers worldwide. Ductal Carcinoma in Situ (DCIS) has increased its incidence ...